ANP-005

N/A

Report date: 2025/01/26 16:13:31

Base Information

Drug NameANP-005
Drug Alias NameRRM2 targeting mAb (ANP Technologies)ANP-005
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionRibonucleoside-diphosphate reductase subunit M2 modulators
TargetsRibonucleoside-diphosphate reductase subunit M2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesANP Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesANP Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A